SBI Investment will help manage the drug distributor’s Medipal Innovation Fund, which will invest in entrepreneurs in areas such as drug discovery and healthcare.
Japan-based medical supplies vendor Medipal Holdings has partnered SBI Investment, an investment subsidiary of financial services firm SBI Holdings, to form a ¥10bn ($92m) corporate venture capital (CVC) vehicle.
Medipal Innovation Fund is intended to operate for 10 years and will mainly target domestic and international startups developing technologies strategically relevant to Medipal’s business lines.
Founded in 1898, Medipal runs group companies in areas including pharmaceuticals, orphan drug discovery, medical and beauty care, and animal health products.
The company has…
